AUSTIN, Texas, Oct. 6, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in improving patient outcomes through genetic and cell-free DNA (cfDNA) testing, announced the completion of the VALI
AUSTIN, Texas, Sept. 29, 2021 /PRNewswire/ --  Natera, Inc.  (NASDAQ: NTRA), is pleased that the Delaware Federal District Court ruled today that all three patents CareDx has asserted against Natera
The stock price of Natera, a clinical genetic testing company, has seen a 14% rise over the last twenty-one trading days, while it is up 30% year-to-date. The recent rise in the stock can be attribute
Rowan Chapman, at Natera (NASDAQ:NTRA), made a large buy and sell of company shares on September 17, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange
AUSTIN, Texas, Sept. 17, 2021 /PRNewswire/ -- Natera, Inc.  (NASDAQ: NTRA), a leader in cell-free DNA testing, today announced new data being presented by the company and its collaborators on the use
AUSTIN, Texas, Sept. 9, 2021 /PRNewswire/ --   Natera, Inc. (NASDAQ: NTRA), a leader in transforming care through genetic and cell-free DNA (cfDNA) testing, today announced the launch of Prospera wi
AUSTIN, Texas, Sept. 7, 2021 /PRNewswire/ --  Natera, Inc.  (NASDAQ: NTRA) a leader in transforming care through genetic and cell-free DNA testing, today announced an agreement with NRG Oncology, a
Naturally Splendid Enterprises Ltd. has announced that Denny's restaurants across Canada will be offering select NATERA meat-alternative entrees on their menus.

New Strong Sell Stocks for August 10th

10:53am, Tuesday, 10'th Aug 2021
THS, ZYME, NTRA, LAWS, and INSW have been added to the Zacks Rank #5 (Strong Sell) List on August 10, 2021
Naturally Splendid Enterprises Ltd. has announced that a fourth shipping container of NATERA Plant Based Foods has been ordered and is being shipped to the company's facility in Pitt Meadows, British
AUSTIN, Texas, Aug. 10, 2021 /PRNewswire/ -- Natera, Inc.  (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that the company's leadership will participate in sev
Natera, Inc. (NTRA) CEO Steve Chapman on Q2 2021 Results - Earnings Call Transcript
Natera (NTRA) delivered earnings and revenue surprises of -25.71% and 1.09%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
AUSTIN, Texas, July 29, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will release results for its second quarter en
AUSTIN, Texas, July 22, 2021 /PRNewswire/ -- Natera,Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced the publication of a new peer-reviewed study validating
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE